EFFECT OF TIRZEPATIDE ON WEIGHT LOSS IN PATIENTS WITH TYPE 2 DIABETES
DOI:
https://doi.org/10.51891/rease.v12i11.32166Keywords:
Tirzepatide, Type 2 diabetes mellitus, Weight lossAbstract
INTRODUCTION: Cases of obesity have increased substantially; these are generally associated with type 2 diabetes mellitus (T2DM), which, in turn, is linked to the development of various metabolic disorders, such as cardiovascular and cerebrovascular diseases and dyslipidemia, among others. OBJECTIVE: To describe the effects of tirzepatide on weight loss in patients with T2DM. METHOD: A literature review of clinical trial or randomized controlled trial articles published in digital databases such as Scielo, PubMed, and LILACS. RESULTS: The results demonstrated that patients with T2DM can lose more weight than non-diabetic patients and that this weight loss can be sustained. In addition, patients experienced benefits such as sustained glycemic control, reduction in fat mass, improvement in metabolic parameters, reduction in blood pressure, reduction in cholesterol levels, and reduction in cardiometabolic risk. CONCLUSION: Tirzepatide is effective for weight loss in T2D and also yields positive outcomes such as sustained weight loss, sustained glycemic control, metabolic improvement, and reduced cardiovascular risk.
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY